Trial Profile
A Phase 3, Randomized, Controlled, and Blinded Clinical Trial to Evaluate Safety and Immunogenicity of 10µg/0.5ml Hepatitis B Vaccine for Infants and Other Age Groups
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Jul 2022
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine-Beijing Tiantan Biological Products Co (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Pharmacodynamics
- 09 Jul 2015 New trial record